2Lawal TA,Chatoorgoon K,Collins MH. Redo pullthrough in Hirschprung's disease for obstructive symptoms due to residual aganglionosis and transition zone bowel[J].Journal of Pediatric Surgery,2011,(02):342-347.
3Pini Prato A,Felici E,Gentilino V. Uncommon causes of postoperative chronic diarrhoea mimicking enterocolitis in Hirschsprung's disease:is there a role for digestive endoscopy[J].Pediatric Surgery International,2008,(04):503-507.doi:10.1007/s00383-007-2071-y.
4Elhalaby EA,Coran AG,Blane CE. Enterocolitis associated with Hirschsprung's disease:A clinical radiological characterization based on 168 patients[J].Journal of Pediatric Surgery,1995,(01):76-83.
5Hirsch BZ,Angelides AG,Goode SP. Rectal biopsies Obtained with Jumbo biopsy forceps in the evaluation of Hirschsprung disease[J].Journal of Pediatric Gastroenterology and Nutrition,2011,(04):429-432.
3I MULDER SA, VAN LEERDAMME, OUWENDIJK ILl, et al. At- tendance atsurveillanceendoscopyof patientswithadenomaor colorec- tal cancer[J]. ScandJ Gastroenterol, 2007, 42(1): 66-71.
4KIM DH, POOLER BD, WEISS JM, et al. Five year colorectal cancer outcomes in a large negative CT colonography screening cohort[J]. Eur Radiol, 2012, 22(7): 1458-1494.
5BROCHIER S, GALLAND F, KUJAS M, et ak Factors predicting relapse of nonfunctioning pituitary macroadenomas after neuro- surgery: a study of 142 patinets[J]. Eur J Endocrinol, 2010, 163 (2): 193-200.
6BERTARIO L, RUSSO A, SALA P, et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients [J]. Int J Caccer, 2003, 105(1): 82-87.
7LAIYEMO AO, MURPHY G, ALBERT PS, et al. Postpolypecto- my colonoscopy surveillance guidelines:predictive accuracy for ad- vanced adenoma at 4 years [J]. Ann Intern Med, 2005, 145(6): 419-426.
8PINSKY PF, SCHOEN RE, WEISSFELD JL, et al. The yield of surveillance colonocopy by adenoma history and time to exami- nation[J]. Clin Gastroenterol Hepatol, 2009, 7(1): 86-92.
9REX DK, JOHNSON DA, ANDERSON JC, et al. American college of gastroenterology guidelines for colorectal cancer screening 2009. american oollege of gastroenterology [J]. Am J Gastroenterol, 2009, 104(3): 739-750.
10THOMPSON P, ROE DJ, FALES L, et al. Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention [J]. Cancer Prey Res(Phila), 2012, 5(12): 1381-1393.
